Two approaches to discovering and developing new drugs for Chagas disease
This review will focus on two general approaches carried out at the Sandler Center, University of California, San Francisco, to address the challenge of developing new drugs for the treatment of Chagas disease. The first approach is target-based drug discovery, and two specific targets, cytochrome P...
Main Authors: | JH McKerrow, PS Doyle, JC Engel, LM Podust, SA Robertson, R Ferreira, T Saxton, M Arkin, ID Kerr, LS Brinen, CS Craik |
---|---|
Format: | Article |
Language: | English |
Published: |
Instituto Oswaldo Cruz, Ministério da Saúde
2009-07-01
|
Series: | Memórias do Instituto Oswaldo Cruz. |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762009000900034 |
Similar Items
-
Novel structural CYP51 mutation in Trypanosoma cruzi associated with multidrug resistance to CYP51 inhibitors and reduced infectivity
by: Caio H. Franco, et al.
Published: (2020-08-01) -
Chemical–biological characterization of a cruzain inhibitor reveals a second target and a mammalian off-target
by: Jonathan W. Choy, et al.
Published: (2013-01-01) -
Cytotoxicity and trypanocidal activity of nifurtimox encapsulated in ethylcyanoacrylate nanoparticles
by: GITTITH SÁNCHEZ, et al.
Published: (2002-01-01) -
Analysis of expressed sequence tags from Trypanosoma cruzi amastigotes
by: Gustavo C Cerqueira, et al.
Published: (2005-07-01) -
Trypanocidal Activity of Long Chain Diamines and Aminoalcohols
by: Ana L. Legarda-Ceballos, et al.
Published: (2015-06-01)